US plans $2.8B bomb sale to Israel
Analysis based on 33 articles · First reported Sep 15, 2026 · Last updated Sep 17, 2026
The proposed package is likely to support US defense contractors and heavy-bomb production lines while reinforcing expectations of continued US military support for Israel, which can keep Middle East risk premia elevated. It may also add to geopolitical tension with Iran and criticism from allies, weighing modestly on broader risk sentiment even as defense-sector shares benefit.
The Trump administration is planning a $2.8 billion arms package for Israel that would include 40,000 2,000-pound bombs, made up of 20,000 Mk84s and 20,000 BLU-117s, according to two US officials and a person familiar with the plan. The package is not yet final, but Congress has been informally notified. Most of the deal is expected to be financed through US foreign military financing, under which US taxpayer funds are provided to Israel to purchase American-made weapons. The sale follows earlier Trump administration moves to expand Israeli military capacity, including a nearly $3 billion sale last year with more than 35,500 of the bombs and a $6.67 billion series of arms sales approved in January. The Biden administration had paused one shipment of the 2,000-pound bombs in 2024 over concerns about mass casualties in densely populated Gaza, and Trump lifted that hold after returning to office. The proposed package comes amid a fragile US-brokered ceasefire in Gaza, continued Israeli strikes and militant attacks, and increasing international isolation of Israel over the war that began after the October 7, 2023 Hamas-led attack. Gaza's Health Ministry has reported more than 73,264 Palestinian deaths, including those recorded since the ceasefire, according to the articles.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard